Anton Gueth, Director at ANTARES PHARMA, INC. (ATRS), sold 100,000 shares at $4.29 ($429K) on 2021-07-08, disclosed to the SEC on 2021-07-09.
Open-market sale of $429k ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2013-09-05 | $111K | — | Filing → |
| ATRS | SELL | 2013-08-05 | $110K | — | Filing → |
| ATRS | SELL | 2013-07-03 | $104K | — | Filing → |